Compare QURE & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | ASGN |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2007 | 1992 |
| Metric | QURE | ASGN |
|---|---|---|
| Price | $22.82 | $49.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $58.55 | $48.60 |
| AVG Volume (30 Days) | ★ 2.0M | 459.1K |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.96 |
| Revenue | $15,751,000.00 | ★ $3,985,300,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142.93 | $0.57 |
| P/E Ratio | ★ N/A | $16.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.76 | $39.25 |
| 52 Week High | $71.50 | $95.29 |
| Indicator | QURE | ASGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.78 | 52.64 |
| Support Level | $21.15 | $48.78 |
| Resistance Level | $28.77 | $50.12 |
| Average True Range (ATR) | 1.60 | 1.48 |
| MACD | 0.23 | -0.10 |
| Stochastic Oscillator | 21.85 | 55.84 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.